News of the WeekGene Therapy

As Gelsinger Case Ends, Gene Therapy Suffers Another Blow

See allHide authors and affiliations

Science  18 Feb 2005:
Vol. 307, Issue 5712, pp. 1028
DOI: 10.1126/science.307.5712.1028b

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Five years after 18-year-old Jesse Gelsinger died in a gene therapy experiment, the U.S. Department of Justice has reached a settlement with the researchers and with their institutions.